Correlation Between Medicenna Therapeutics and Resverlogix Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medicenna Therapeutics and Resverlogix Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicenna Therapeutics and Resverlogix Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medicenna Therapeutics Corp and Resverlogix Corp, you can compare the effects of market volatilities on Medicenna Therapeutics and Resverlogix Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicenna Therapeutics with a short position of Resverlogix Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicenna Therapeutics and Resverlogix Corp.

Diversification Opportunities for Medicenna Therapeutics and Resverlogix Corp

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Medicenna and Resverlogix is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Medicenna Therapeutics Corp and Resverlogix Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Resverlogix Corp and Medicenna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicenna Therapeutics Corp are associated (or correlated) with Resverlogix Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Resverlogix Corp has no effect on the direction of Medicenna Therapeutics i.e., Medicenna Therapeutics and Resverlogix Corp go up and down completely randomly.

Pair Corralation between Medicenna Therapeutics and Resverlogix Corp

Assuming the 90 days trading horizon Medicenna Therapeutics Corp is expected to generate 0.93 times more return on investment than Resverlogix Corp. However, Medicenna Therapeutics Corp is 1.07 times less risky than Resverlogix Corp. It trades about 0.05 of its potential returns per unit of risk. Resverlogix Corp is currently generating about 0.0 per unit of risk. If you would invest  76.00  in Medicenna Therapeutics Corp on August 26, 2024 and sell it today you would earn a total of  81.00  from holding Medicenna Therapeutics Corp or generate 106.58% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Medicenna Therapeutics Corp  vs.  Resverlogix Corp

 Performance 
       Timeline  
Medicenna Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medicenna Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Resverlogix Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Resverlogix Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Medicenna Therapeutics and Resverlogix Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medicenna Therapeutics and Resverlogix Corp

The main advantage of trading using opposite Medicenna Therapeutics and Resverlogix Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicenna Therapeutics position performs unexpectedly, Resverlogix Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Resverlogix Corp will offset losses from the drop in Resverlogix Corp's long position.
The idea behind Medicenna Therapeutics Corp and Resverlogix Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios